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Background and purpose: To estimate target and cardiac doses from breast cancer radiotherapy in Den-
mark and in the Stockholm and Umeå areas of Sweden during 1977–2001.
Methods: Representative samples of irradiated women were identiﬁed from the databases of the Danish
Breast Cancer Cooperative Group and the Swedish Nationwide Cancer Registry. Virtual simulation, com-
puted tomography planning and manual planning were used to reconstruct radiotherapy regimens on a
typical woman. Estimates of target dose and various measures of cardiac dose were derived from individ-
ual radiotherapy charts.
Results: Doses were estimated in 681 Danish and 130 Swedish women. Mean heart dose for individ-
ual women varied from 1.6 to 14.9 Gray in Denmark and from 1.2 to 22.1 Gray in Sweden. In Den-
mark, mean target doses averaged across women increased from 40.6 to 53.8 Gray during 1977–
2001 but, despite this, mean heart dose averaged across women remained around 6 Gy for left-sided
and 2–3 Gray for right-sided radiotherapy. In Sweden mean target dose averaged across women
increased from 38.7 to 46.6 Gray during 1977–2001, while mean heart dose averaged across women
decreased from 12.0 to 7.3 Gray for left-sided and from 3.6 to 3.2 Gray for right-sided radiotherapy.
Temporal trends for mean biologically effective dose [BED] to the heart, mean dose to the left ante-
rior descending coronary artery, the right coronary artery and the circumﬂex coronary artery were
broadly similar.
Conclusions: Cardiac doses in Denmark were low relative to those in Sweden. In both countries, tar-
get dose increased during 1977–2001. Despite this, cardiac doses remained constant in Denmark and
decreased in Sweden.
 2011 Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.
Radiotherapy and Oncology 100 (2011) 176–183Radiotherapy for early breast cancer reduces the risk of local
recurrence and can reduce the risk of death from breast cancer.
However, treatment usually involves some unwanted irradiation
of the heart and this may result in an increased risk of heart dis-
ease. The most recent overview of the long-term follow-up of data
from the randomised trials of radiotherapy for early breast cancer
found that there was a highly signiﬁcant 27% increase in relative
risk of mortality from heart disease in women randomised to
radiotherapy [1]. Cardiac radiation doses are usually higher in
left-sided than in right-sided breast cancer and observational stud-
ies following women in the general population after a diagnosis ofService Unit, Richard Doll
. Taylor).
nder CC BY-NC-ND license.breast cancer have also found higher cardiac mortality in women
with left-sided cancers compared with women with right-sided
cancers [2,3].
Radiotherapy techniques have changed over the past few dec-
ades enabling improved dose distributions to be delivered to target
tissues. However, current radiotherapy regimens still deliver some
dose to cardiac structures [4,5]. In some women with left-sided
breast cancer the target tissue coverage is currently being compro-
mised due to the limits that have been set on cardiac dose, and it is
not known whether such limits have at present been set at the
most appropriate levels. For other women, the cardiac dose is low-
er and does not limit the dose to the target tissue, but it is not at
present known whether such women will in the future incur any
increase in cardiac risk. Appropriate levels for constraints during
radiotherapy planning and also reliable estimation of the future
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require accurate estimates of the dose–response relationship for
radiation-induced heart disease. As part of a programme of work
to derive such relationships, detailed dosimetry based on the origi-
nal radiotherapy charts has been carried out to estimate individual
heart and coronary artery doses and also target doses for a large
number of women who were irradiated in Denmark during the
period 1977–2001. The present paper describes the method used
to estimate these doses.
The ﬁrst uniform nationwide protocol for breast cancer radio-
therapy in Denmark was issued in 1977 [6]. This protocol was re-
vised in 1982, in 1989 and again in 1999. The present paper,
therefore, presents target and cardiac doses for a representative
sample of women who were irradiated in Denmark for breast can-
cer in the periods covered by these protocols. As part of the same
research programme, cardiac doses have also been estimated using
similar methodology for a large number of women who were irra-
diated in the Stockholm and Umeå areas of Sweden [7] and the
present paper also presents doses for a representative sample of
women irradiated in this area of Sweden during the same time
periods.Methods
Selection of women
The database of the Danish Breast Cancer Cooperative Group
(DBCG) [8] was used to identify all women irradiated for breast
cancer in Denmark during 1977–2001 at ages <75 years. Within
this population, women developing or dying from ischaemic heart
disease were identiﬁed from the Danish hospital inpatient and out-
patient registers and from death certiﬁcates. For each of the wo-
men with heart disease (i.e., each ‘case’ woman), 2 control
women were selected. Doses were reconstructed for all the cases
and for all the controls using the method described below.
A total of 681 women were selected as controls and this paper
presents the estimated doses for these 681 women. The method
used to select these control women was as follows. For each case,
all the women in the study population were identiﬁed who had
been diagnosed with breast cancer during the same 5-year calen-
dar period as the case, who were in the same 5-year age group
as the case, and who had not developed heart disease by the time
the case woman had developed heart disease (or had died, for cases
who were identiﬁed from death certiﬁcates). From the pool of eli-
gible controls for each case, two were selected at random. The
selection was with replacement, so that some women were chosen
as controls for more than one case, which accounts for the fact that
the total number of women selected as controls is not precisely
equal to twice the number of case women. A consequence of this
method of selection is that within each calendar period, the wo-
men selected as controls had an age distribution reﬂecting that
of the women who subsequently developed heart disease, rather
than that of the population of irradiated breast cancer patients.
To examine the consequence of this, average mean heart doses
were calculated separately for women aged 20–49, 50–59, 60–69
& 70–79 at breast cancer diagnosis for left-sided and right-sided
cancers for calendar periods 1977–1981, 1982–1988 & 1989–
2001. Values for the different age groups were similar, with no sug-
gestion of any trend. We, therefore, conclude that, for each calen-
dar period, the estimated doses are representative of the doses
delivered to the entire population of irradiated breast cancer pa-
tients in Denmark.
The method of selection of the 130 Swedish women presented
in this paper was similar to that used for the 681 Danish women.
The method used to reconstruct the doses of the Swedish women
has been described elsewhere [7].Categorisation of radiotherapy charts
Each woman’s radiotherapy chart, including a photograph of
the treatment ﬁelds and a dose-plan (if available) was copied. In
the rare cases (less than 1% of women) where the chart was not
available, information on the regimen used was sought from the
woman’s medical notes. The charts were used to extract details
on regimens used to irradiate the breast, chest wall and internal
mammary chain for each woman. Details of regimens used to irra-
diate only the supraclavicular fossa or axilla were not obtained
since their contribution to heart dose is usually an order of magni-
tude lower than from breast, chest wall and internal mammary
chain radiotherapy [9]. Each woman’s radiotherapy chart was cat-
egorised according to the regimen she received. This included de-
tails of radiotherapy technique(s) used, laterality, target dose(s)
and fraction size(s) and whether she received either supraclavicu-
lar fossa or axillary irradiation.Set-up of typical radiotherapy regimens
Each radiotherapy regimen was reconstructed using a tech-
nique based on virtual simulation and computed tomography
(CT) based 3-dimensional treatment planning. All the regimens
were reconstructed on the CT planning scan of a typical patient
of average build who had been selected from the radiotherapy
planning database of a UK radiotherapy department. The heart
and coronary arteries were contoured. The cranial limit of the heart
included the right atrium and excluded the pulmonary trunk,
ascending aorta and superior vena cava. The lowest contour of
the heart was the caudal myocardial border. The heart contour in-
cluded heart muscle and circulating blood volume; it did not in-
clude the pericardium. The left main coronary artery arises from
the aorta and branches into the left anterior descending (LAD)
and circumﬂex coronary arteries. Due to its short length, its con-
tour was included with that of the LAD coronary artery. The cir-
cumﬂex coronary artery was contoured from the branch point of
the left main coronary artery. The right coronary artery was con-
toured from its origin at the aorta.
Beam modalities employed were 6 MV, cobalt-60 and 10 MeV
electrons. Dose calculations for 100 and 250 keV ﬁelds were car-
ried out using manual planning. The algorithms used for the dose
calculations were the pencil beam [10,11] and the collapsed cone
superposition convolution algorithms [12,13]. The former was
used for all regimens and the latter for a selection of regimens that
involved regions of substantial tissue inhomogeneity. Agreement
between algorithms was within 2% of dose for all regimens.Dose calculations
For each regimen, dose–volume histograms (DVHs) were gener-
ated for the heart and for each of the three main coronary arteries.
These were used to estimate mean dose and biologically effective
dose (BED) to each cardiac structure using the linear quadratic
model: BED = [nd(1 + d/(a/b)] where n is number of fractions and
d is dose per fraction in Gray (Gy). An alpha–beta ratio of 2 Gy
was used as previously described [7]. Other measures of dose, such
as maximum dose to each structure were estimated but not pre-
sented since they are likely to vary substantially from patient to
patient.
Left-sided supraclavicular fossa and/or axillary irradiation has
previously been estimated to deliver around 0.5 Gy mean dose to
the heart and to each of the three main coronary arteries [9].
Therefore, for women who received left-supraclavicular fossa or
axillary radiotherapy, 0.5 Gy dose was added to the mean heart
and coronary artery doses calculated from irradiation of the other
targets. Right-sided supraclavicular fossa and axillary ﬁelds are
Table 1
Estimated cardiac doses from common breast cancer radiotherapy regimens used to irradiate the breast, chest wall and internal mammary nodes in Denmark from 1977 to 2001.
Description Usual given or
target dose (Gy)A
Usual dose per
fraction (Gy)
Field
arrangement
Usual beam
energy
Number
women
Heart LADD RCAE CircF
Mean dose
(Gy)B
Mean BED
(Gy2)C
Mean dose
(Gy)B
Mean BED
(Gy2)C
Mean dose
(Gy)
Mean dose
(Gy)
Left Right Left Right Left Right Left Right Left Right Left Right
Regimens common during 1977–1981G
Lateral thorax (and supraclavicular fossa) ﬁeld (a)H,I 45.0 3.75 Oblique anterior 8–18 MV 173 3.0 1.9 4.5 2.7 9.0 0.8 14.9 0.9 2.9 5.4 1.5 0.5
Electron ﬁeld to chest wall and internal mammary chain 40.7 3.39 Direct anterior 10 MeV
Wide tangential pair to chest wall (b) 40.7 1.85 Wide tangential pair 6 MV 58 8.5 2.7 14.9 3.8 23.5 1.6 45.7 2.0 3.3 11.0 3.6 1.0
McWhirter (c) 23.6–36.0 1.80 Wide tangential pair 250–300 keVJ 46 14 9 25 13 43 5 – – 10 19 7 4
Lateral thorax (and supraclavicular fossa) ﬁeld (a) 45.0 3.75 Oblique anterior 4 MV 22 4 2 5 3 6 1 – – 2 2 2 1
Orthovoltage scar boost (d) 36.0 3.00 Direct anterior 100 keVJ
Regimens common during 1982–1988G
Lateral thorax (and supraclavicular fossa) ﬁeld (e) 50.0–55.0 2.00–2.20 Oblique anterior 4–10 MV 114 4.5 3.0 6.0 3.9 12.8 1.1 18.1 1.2 5.3 8.9 2.0 0.7
Electron ﬁeld to internal mammary chain 54.0 2.16 Direct anterior 9–14 MeV
Electron ﬁeld to chest wall 50.0 2.00 Direct anterior 6–10 MeV
Tangential pair to breast (midline) (f) 50.0 2.00 Tangential pair 6–10 MV 6 6.0 1.7 9.2 1.9 23.5 1.4 41.6 1.7 2.2 3.2 3.0 1.1
Regimens common during 1989–2001G
Tangential pair to breast (midline) (f) 48.0 2.00 Tangential pair 6–10 MV 132 6.1 1.7 11.9 1.9 24.0 1.4 58.5 1.5 2.1 3.3 3.0 1.1
Electron scar boost (g) 10.8 2.16 Direct oblique 8–15 MeV
Tangential pair to breast (midline) (f) 48.0 2.00 Tangential pair 6–10 MV 59 6.3 1.8 12.4 1.9 24.8 1.5 62.8 1.6 2.3 3.4 3.0 1.1
Tangential scar boost (h) 10.0 2.00 Tangential pair 6–25 MV
Oblique electron ﬁeld to breast/chest wall (i) 51.9 2.16 Oblique anterior 8–15 MeV 27 4.7 2.1 7.2 2.6 17.6 0.6 35.2 0.6 2.7 6.4 2.0 0.6
Electron scar boost (g) 10.8 2.16 Direct oblique 8–18 MeV
Oblique electron ﬁeld to breast/chest wall (i) 51.9 2.16 Oblique anterior 8–15 MeV 15 4.4 2.0 6.0 2.5 16.2 0.6 26.1 0.9 2.6 6.2 1.9 0.6
Wide tangential pair to breast/chest wall (b) 48.0 2.00 Wide tangential pair 6–18 MV 10 10.3 3.3 18.1 4.2 29.1 1.9 59.9 1.7 3.9 13.2 4.3 1.2
Electron scar boost (g) 10.8 2.16 Direct oblique 6–18 MeV
Estimates based on typical tumour dose and calculated on a representative patient with typical anatomy.
Each regimen presented was received by P5 of the 681 women included in the study. Nineteen of the 681 women received other, less commonly used, regimens.
A Given dose, i.e., dose at Dmax (maximum dose) where different from prescribed dose.
B For some regimens, cardiac doses differed slightly from those of the patients described in Fig. 2 since tumour dose varied slightly from patient to patient.
C BED (biologically effective dose) calculated using the linear quadratic equation: BED = [nd(1 + d/(a/b)] where n is number of fractions and d is dose per fraction in Gy. a/bwas assumed to be 2. BEDs were based on average doses
in ﬁrst 300 women in the study except for wide tangential pair/electron scar boost and McWhirter regimens where there was more than 5 Gy difference between tumour doses for the ﬁrst 300 women and ﬁnal 681 women. LAD
coronary artery BEDs are not presented for manually planned techniques since they are based on few dose points.
D Left anterior descending coronary artery.
E Right coronary artery.
F Circumﬂex coronary artery.
G New protocols were introduced in these years.
H (a), (b) etc. refers to the illustrations in Fig. 1.
I Regimen comprises both techniques, i.e., lateral thorax and chest wall & internal mammary chain.
J Doses for manually planned regimens are rounded due to the uncertainties involved in planning. All other doses are given to 1 decimal place.
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doses to cardiac structures. Therefore, adjustments were not car-
ried out for women treated with right-supraclavicular fossa or ax-
illary radiotherapy. BEDs to the heart and coronary arteries depend
on dose and dose per fraction. Therefore, it was not possible to ad-
just cardiac BEDs for the use of supraclavicular fossa or axillary
radiotherapy.
The approximate target dose(s) for each woman were calcu-
lated according to the same deﬁnition in both Denmark and Swe-
den, in order to allow comparison between countries. They were
derived by calculating the dose at the centre of the breast or chest
wall for tangential irradiation, at the approximate depth of the tu-
mour bed for direct orthovoltage chest wall ﬁelds and at the
approximate depth of the internal mammary chain for orthovol-
tage internal mammary ﬁelds. For other direct or oblique chest
wall or internal mammary ﬁelds, target dose was assumed to be
90% of the given dose. For the 6 MV lateral thorax (and supraclavic-
ular fossa) ﬁeld, target dose was assumed to be 100% of the given
dose. For further details of target dose calculation from Swedish
regimens, see Taylor et al. [7].Fig. 1. Danish breast cancer radiotherapy techniques reconstructed for carAverage cardiac doses during different time periods were esti-
mated as follows. Mean heart dose was calculated for each of the
681 women evaluated. The women were then divided according
to time period of irradiation: 1977–1981, 1982–1988 or 1989–
2001. The average of the mean heart doses was calculated for each
period. This was repeated for doses to the coronary arteries. Aver-
age target dose was estimated in the same way, taking account of
all of the anatomical regions irradiated.Results
Breast cancer radiotherapy regimens
Information on radiotherapy regimen was sought for 681 Dan-
ish women. Radiotherapy charts were available for 677 of the 681
women (99%) and radiotherapy regimen was ascertained for all
681 women. The total number of different breast cancer radiother-
apy regimens found between the years 1977 and 2001 in Denmark
was 36. Twenty-two of these regimens (11 left-sided and 11 right-diac dose estimations, ordered according to time period of irradiation.
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Fig. 2. Estimated mean heart (panel a) and left anterior descending coronary artery (LAD) (panel b) doses in Danish breast cancer patients irradiated between 1977 and 2001.
Dose for the left-sided patients is represented by black bars and dose for the right-sided patients, by grey bars. Estimates are based on individual patient doses. Regimens
were reconstructed on a typical patient with average anatomy.
180 Cardiac doses from breast cancer RTsided) were received by ﬁve or more of the 681 women. Details of
these regimens are summarised on Table 1 and Fig. 1.
Information on Swedish breast cancer regimens used during
this time period can be found in Taylor et al. 2009 [7].Heart dose from Danish breast cancer regimens
From 1977 until 1988 most women irradiated for breast cancer
received an electron ﬁeld to the chest wall +/ the internal mam-
mary chain (Fig. 1a and e, Table 1). Most women also received
megavoltage irradiation of the lateral thorax and supraclavicular
fossa (Fig. 1a and e, Table 1). The energy of the direct or oblique
electron ﬁelds depended on each woman’s soft-tissue thickness.
The greater the soft-tissue thickness, the greater the energy of elec-
trons used. These regimens usually delivered estimated mean
heart dose of around 3–5 Gy (BED 4–6 Gy2) for left-sided and
around 2–3 Gy (BED 2–4 Gy2) for right-sided radiotherapy(Table 1). Some women in the study received bolus to the chest
wall ﬁeld, others were treated without bolus. The difference that
1 cm bolus made to estimated mean heart dose was 1 Gy for left-
sided irradiation, and less than this for right-sided irradiation. A
small volume of the heart anteriorly received between 20 Gy and
50 Gy. Most of the heart volume received less than 10 Gy due to
the rapid decrease in dose from the electron ﬁelds. The megavolt-
age ﬁeld used to irradiate the lateral part of the thorax was distant
from the heart and contributed only 0.8 Gy estimated mean heart
dose for left-sided and 0.6 Gy for right-sided radiotherapy (data
not shown).
In some parts of Denmark there was no access to megavoltage
or electron treatment in the 1970s and early 1980s. Instead, tan-
gential orthovoltage irradiation of the chest wall and internal
mammary chain was used (McWhirter technique) (Fig. 1c) [14].
This delivered mean estimated doses of 14 Gy (BED = 25 Gy2) to
the heart for left-sided and 9 Gy (BED = 13 Gy2) for right-sided
C.W. Taylor et al. / Radiotherapy and Oncology 100 (2011) 176–183 181radiotherapy (Table 1). These high heart doses are partly explained
by lateral scatter and partly by the depth–dose characteristics of an
orthovoltage beam.
During the period 1989–2001, an increasing number of women
received breast-conserving surgery with postoperative megavolt-
age tangential irradiation of the conserved breast (Fig. 1f). Most
women also received a boost to the tumour bed with electrons
(Fig. 1g) or with tangential beams (Fig. 1h) if the tumour was
deep-seated. Standard tangential irradiation of the whole breast
or chest wall (Fig. 1f) +/ boost radiotherapy usually resulted in
estimated mean heart doses of around 6 Gy (BED 10 Gy2) for
left-sided and 2 Gy (BED 2 Gy2) for right-sided radiotherapy
(Table 1).Coronary artery doses from Danish breast cancer regimens
Dose to the LAD coronary artery was greater for left-sided than
for right-sided regimens due to its anatomical position close to the
left breast and left internal mammary chain. The artery tended to
receive the highest radiation doses of more than 20 Gy estimatedTable 2
Cardiac dose estimates for Danish women identiﬁed using the Danish Breast Cancer Group
charts.
Year of radiotherapya Number of women evaluated Average mean dose (standard
Target dose (Gy) Heart dose
Left Rig
1977–1981 199 40.6 6.1 2.
(6.3) (3.3) (1.
1982–1988 187 48.4 5.7 2.
(6.6) (2.3) (1.
1989–2001 295 53.8f 5.8 2.
(5.1) (1.2) (0.
Regimens were reconstructed on a representative patient with typical anatomy.
a Women were grouped according to the years that breast cancer protocols changed
DBCG82 protocol between 1982 and 1988 and the DBCG89 protocol between 1989 and
b The biologically effective dose (BED) takes into account the fraction size as well as dos
per fraction in Gy. a/bwas assumed to be 2 Gray. It was possible to calculate BEDs for 97%
who received unusual techniques such as iridium wire radiotherapy.
c Left anterior descending coronary artery.
d Right coronary artery.
e Circumﬂex coronary artery.
f Target dose includes boost radiotherapy.
Table 3
Cardiac dose estimates for Swedish women identiﬁed using the Swedish nationwide cancer
charts.
Year of radiotherapya Number of women evaluated Average mean dose (standar
Target dose (Gy) Heart do
Left
1977–1981 36 38.7 12.0
(10.2) (5.2)
1982–1988 51 44.6 8.0
(8.8) (5.8)
1989–2001 43 46.6 7.3
(8.5) (7.2)
Regimens were reconstructed on a representative patient with typical anatomy.
a Women were grouped according to the years that breast cancer protocols changed
b The biologically effective dose (BED) takes into account the fraction size as well as dos
per fraction in Gy. a/b was assumed to be 2 Gray. It was possible to calculate BEDs for wo
planned technique (91% of the women studied). It was not possible to calculate BED for t
(9% of the women studied).
c Left anterior descending coronary artery.
d Right coronary artery.
e Circumﬂex coronary artery.mean dose (BED 40–60 Gy2) and around 50 Gy estimated maxi-
mum dose (data not shown) from left-tangential radiotherapy
(Figs. 1b,c,f, Table 1) since parts of the artery were close to, or in-
cluded in, the radiation ﬁelds. LAD coronary artery dose from left
electron radiotherapy was around 9–18 Gy (BED 15–35 Gy2),
with maximum doses of between 44 and 52 Gy (data not shown).
There is likely to be considerable interpatient variability in maxi-
mum dose to the LAD coronary artery since it is usually close to
the edge of the ﬁelds.
The right coronary artery is located anteriorly, slightly to the
right of midline and it received the highest doses from right-sided
regimens. The circumﬂex coronary artery is located posteriorly,
distant from the breast and internal mammary chain and for most
regimens it received lower dose than the heart or the other two
coronary arteries.Heart and coronary artery doses for Danish women
Estimated heart dose for the 681 Danish women varied from 1.6
to 14.9 Gy mean dose (Fig. 2a) and from 1.9 to 25.3 Gy2 mean BED.database and irradiated for breast cancer since 1977, based on individual radiotherapy
deviation)
(Gy) Heart BEDb (Gy2) LADc dose (Gy) RCAd dose (Gy) Circe dose (Gy)
ht Left Right Left Right Left Right Left Right
9 10.2 4.6 16.4 1.5 4.2 7.7 3.1 1.1
6) (7.9) (3.7) (9.7) (1.2) (1.9) (4.0) (1.4) (0.9)
9 8.4 3.9 16.3 1.4 4.2 8.2 2.8 0.9
1) (5.9) (2.5) (7.2) (0.8) (1.5) (3.3) (1.0) (0.6)
1 10.1 2.4 20.9 1.3 3.0 5.3 2.8 0.9
5) (3.2) (0.8) (5.3) (0.3) (1.3) (2.8) (0.6) (0.2)
in Denmark. The DBCG77 protocol was mainly used between 1977 and 1981; the
2001.
e and is given by BED = [nd(1 + d/(a/b)] where n is number of fractions and d is dose
of the women studied. It was not possible to calculate BED for the other 3% women
register and irradiated for breast cancer since 1977, based on individual radiotherapy
d deviation)
se (Gy) Heart BEDb (Gy2) LADc dose (Gy) RCAd dose (Gy) Circe dose
Right Left Right Left Right Left Right Left Right
3.6 20.8 4.5 23.6 1.5 8.7 9.5 7.7 0.8
(3.0) (10.0) (4.0) (7.6) (0.8) (5.4) (9.1) (3.4) (0.3)
3.7 11.6 5.1 21.1 1.9 6.9 11.1 4.2 0.9
(2.4) (10.2) (3.9) (9.0) (1.0) (7.1) (9.9) (2.9) (0.4)
3.2 10.5 4.2 18.8 2.1 5.7 8.4 3.9 1.3
(2.2) (11.2) (3.2) (11.7) (0.7) (6.2) (9.5) (3.3) (0.3)
in Denmark to enable comparison with Danish women in Table 2.
e and is given by BED = [nd(1 + d/(a/b)] where n is number of fractions and d is dose
men who received computer planned technique combinations or a single manually
he other women who received two techniques, one of which was manually planned
182 Cardiac doses from breast cancer RTEstimated coronary artery mean doses in these women varied from
0.4 to 42.8 Gy for the LAD coronary artery (Fig. 2b), from 1.8 to
19.4 Gy for the right coronary artery and from 0.1 to 6.8 Gy for
the circumﬂex coronary artery.Trends in cardiac dose in Denmark and Sweden 1977–2001
Heart doses in Denmark have been consistently low over the
past few decades due to the widespread use of techniques that
spare the heart, namely electron irradiation of the chest wall and
internal mammary chain [15,16], and tangential irradiation with
the medial border on midline. The estimated average mean heart
dose remained fairly constant between 1977 and 2001 at around
5–6 Gray for left-sided and 2–3 Gray for right-sided irradiation
(Table 2).
There was a slight increase in LAD coronary artery dose from
left-sided radiotherapy from 16.4 Gy in 1977–1981 to 20.9 Gy in
1989–2001. This can be partly explained by the increasing use of
tangential radiotherapy which can cause hotspots of high radio-
therapy dose in the anterior part of the heart and partly by the in-
crease in average target dose from 40.6 Gy in 1977–1981 to
53.8 Gy in 1989–2001. Doses to the right coronary artery from
both left- and right-sided irradiation have reduced between 1977
and 2001. There was little change in estimated LAD coronary artery
dose from right-sided irradiation and in circumﬂex coronary artery
doses during this period (Table 2).
In Sweden, mean heart dose for individual women varied from
1.2 to 22.1 Gray, and the estimated average mean heart dose in
1977–1981 was 12.0 Gy for left-sided radiotherapy and 3.6 Gy
for right-sided radiotherapy (Table 3). These doses fell to 7.3 Gy
and 3.2 Gy in 1989–2001 for left-sided and right-sided radiother-
apy, respectively. Similar dose reductions were seen in doses to
each of the three coronary arteries for left-sided irradiation. There
was little change in doses to the LAD, right and circumﬂex coronary
arteries from right-sided irradiation during this time period.
Discussion
The present study has estimated doses to the heart and coro-
nary arteries from breast cancer radiotherapy regimens used in
Denmark between 1977 and 2001. Twenty-two different breast
cancer radiotherapy regimens were commonly used and these re-
sulted in radiation doses of between 1.7 and 14 Gy to the heart and
0.5 and 43 Gy to the coronary arteries. Women irradiated for left-
sided breast cancer generally received higher doses than those irra-
diated for right-sided cancer.Trends in cardiac dose in Denmark and Sweden 1977–2001
Over the past few decades, indications for breast cancer radio-
therapy, the radiotherapy techniques used and beam energies
available have changed substantially throughout the world. Surgi-
cal techniques have also evolved, with the increasing use of breast
conserving surgery since the 1980s. In many countries, these
changes have resulted in reductions in dose to the heart
[4,7,17,18]. The risk of radiation-induced heart disease in breast
cancer survivors is known to be related to radiation dose [19–
22]. This risk is, therefore, likely to have reduced in countries such
as Sweden where cardiac doses reduced substantially between
1977 and 2001, but to have stayed fairly constant in Denmark
where there was little trend in the magnitude of cardiac doses.
Since the year 2001 doses to all cardiac structures from tangen-
tial radiotherapy in Denmark are likely to have reduced due to the
increasing use of CT planned radiotherapy [14,16]. CT based treat-
ment planning provides detailed information about coverage of the
target(s), dose homogeneity and doses to organs at risk. It has beenfound to improve the dose distribution in the target(s) and to re-
duce mean heart dose from around 4.5 Gy with standard left-tan-
gential irradiation to 3.0 Gy with CT-based conformal left-
tangential irradiation [23].Strengths and limitations of the study
Information on typical cardiac and target doses was derived by
studying the radiotherapy charts of women irradiated for breast
cancer. Cardiac doses based on individual radiotherapy regimens
were available for all Danish women and for 99% of Swedish wo-
men and our sample contained more than 600 women in Denmark
and more than 100 women in Sweden irradiated between 1977
and 2001. These women are likely to be representative of the gen-
eral irradiated breast cancer populations in Denmark and Sweden.
Since 1977, radiotherapy in all regions of Denmark has been
delivered according to the DBCG protocols. Information concerning
the different treatment regimens for this study was obtained both
from the DBCG protocols and from the radiotherapy charts or
oncology notes of 681 Danish women. These two sources provided
detailed and consistent information. For most Danish radiotherapy
techniques, there was little geographical or interpatient variation
in parameters such as ﬁeld borders or patient treatment position.
Therefore, reconstruction of regimens on our typical patient is
likely to be representative of reconstruction in previous decades.
However, for boost radiotherapy, the DBCG protocols indicated
that the ﬁeld should encompass the surgical scar with a 3 cm mar-
gin [14]. The radiotherapy charts revealed substantial variability in
boost ﬁeld size and position. Estimated cardiac doses from boost
radiotherapy are, therefore, subject to a higher degree of variability
than doses from other techniques. However, heart dose from boost
irradiation was always low relative to other techniques because of
the low given dose of 6–20 Gy.
The women included in the study were not CT-planned, there-
fore, theirheartdosesneeded tobecalculatedretrospectively. Retro-
spective dosimetry is subject to several sources of variability. The
cardiac doses received by an individual woman are likely to vary
according to her anatomical characteristics and according to the cir-
cumstances of her radiotherapy, such as her treatment position and
the linear accelerator used. Most of these sources of variability
would apply to any retrospective dosimetry method. They are de-
scribedandquantiﬁedbyTaylor et al. [9]. Themost important source
ofdosevariabilitywas foundtobe theeffect of differingpatient anat-
omy. Nevertheless differences in heart dose are usually likely to be
greater for different regimens than for different women [9].
Electron beam energy was usually chosen according to the
thickness of soft tissue for the Danish women in this study. Beam
energies varied from 4 to 22 MeV for breast or chest wall radio-
therapy and from 9 to 18 MeV for internal mammary radiotherapy.
The internal mammary chain and chest wall electron regimens
reconstructed on our typical patient were 10 MeV, based on her
soft tissue thickness. Tailoring of electron energy in individual wo-
men in the study is likely to have reduced the effect of differing pa-
tient anatomy on cardiac doses since higher energy beams were
used for patients with thicker soft tissue.Variation in cardiac doses for Danish women
The current study has estimated cardiac doses for women irradi-
ated in Denmark between 1977 and 2001. For individual women in
the study, there was a wide range of cardiac doses of between 1.6
and14.9 Gymeanheartdoseandbetween0.1and42.8 Gymeancor-
onaryarterydose. Thesedosevariationsoccurredﬁrstlybecausewo-
men irradiated for left-sided cancers usually received higher cardiac
doses than those irradiated for right-sided cancers. Secondly,
although most Danish women received around 5 Gy mean heart
C.W. Taylor et al. / Radiotherapy and Oncology 100 (2011) 176–183 183dose for left-sided and 2 Gy for right-sided radiotherapy (Fig. 2), at
least some women in each decade received regimens that delivered
higher heart doses. For example, in this study some women in the
1970s and 80s received McWhirter radiotherapy, which delivered
around 14 Gy for left-sided and 9 Gy for right-sided radiotherapy,
and some women in the 1990s received wide tangential pair and
electron boost irradiation, which delivered around 10 Gy and 3 Gy
for left- and right-sided radiotherapy, respectively.
However, the majority of women in each decade received elec-
tron radiotherapy or standard tangential pair radiotherapy, which
delivered lower heart doses of around 4–6 Gy for left-sided and
2 Gy for right-sided radiotherapy. Therefore, there was little varia-
tion in cardiac doses received by the irradiated breast cancer pop-
ulation as a whole from decade to decade. This suggests that we
may expect little variation in the risk of radiation-induced heart
disease from decade to decade between 1977 and 2001. These
doses will enable assessment of the risks of radiation-induced
heart disease experienced by Danish breast cancer survivors irradi-
ated during 1977–2001, and contribute toward prediction of the
future risks of heart disease.
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